Molecular Partners AG ADR
MOLN
Molecular Partners AG ADR is a clinical-stage biopharmaceutical company focused on designing and developing DARPin therapeutics, a proprietary protein-based platform used to create highly specific medicines. The company’s current work centers on therapies for oncology, immuno-oncology, ophthalmology, and other serious diseases, with programs spanning preclinical research and clinical trials. Its pipeline includes candidates designed to address solid tumors, blood cancers, retinal disorders, and other conditions where targeted protein engineering may offer therapeutic value. Molecular Partners AG ADR plays a specialized role in the biotechnology market by advancing novel biologic drug candidates and platform technologies for potential use in precision medicine. Headquartered in Schlieren, Switzerland, the company operates as a research-driven developer of innovative protein therapies for global healthcare applications.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
CHF 0.00
▼ -100.0% YoY
Net Income (TTM)
-CHF 51M
▼ -14.1% YoY
Op. Margin
–
ROIC
-38.41%
▼ -8.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-CHF 46M
▲ +13.3% YoY
Op. Cash Flow (TTM)
-CHF 46M
▲ +12.7% YoY
Net Debt
-CHF 89M
Net Cash Position
Cash & Equiv.
CHF 93M
Continue Research
Peers
Biotechnology · Pick stocks to compare with MOLN
Molecular Partners AG ADR (MOLN) in three numbers
Questions about Molecular Partners AG ADR
Is Molecular Partners AG ADR a high-quality business?
Molecular Partners AG ADR scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$89M, and its weakest is return on capital at -38.4%. The Quality tab shows every check against its target.
Does Molecular Partners AG ADR (MOLN) pay a dividend?
No. Molecular Partners AG ADR (MOLN) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MOLN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.